Delivery Order SPE2DB22D2006-SPE2DB25FW2QQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $29,314.76 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count units) under a firm fixed-price contract. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025. This non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's critical role in supporting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $18,011.60 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count bottles) under a firm fixed-price contract. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg with a ceiling value of $1,910.48 under a firm fixed-price contract. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery against an existing contract vehicle. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,178.76 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg on June 27, 2025, with completion expected by June 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a ceiling value of $1,801.16. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary hub for pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,446.16 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,690.75 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) under a firm fixed price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $18,938.90 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100 count) under a firm fixed price contract. This non-competitive delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $21,960.62 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract represents a continuation of AmerisourceBergen's critical role as a...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2QQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,058.71 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count units) under a firm fixed price arrangement. The contract, which commenced on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against an existing Indefinite Delivery Contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The pharmaceutical distributor serves as a critical vendor for federal medical procurement and maintains extensive experience fulfilling military and veteran healthcare supply requirements through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract establishes a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The DLA Troop Support Medical Supply Chain leverages this vehicle to fulfill episodic pharmaceutical requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the strategic importance of pharmaceutical prime vendors in supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 7/18/25 |